Track topics on Twitter Track topics that are important to you
The University of British Columbia licensed PureTech Health PLC's Commense Inc. subsidiary a microbiome-based therapy for childhood asthma and other allergic diseases.
Commense has licensed from the University of British Columbia a microbiome-based therapeutic for the prevention of asthma and -More-
In this episode of the Biotechnology Focus Radio, we discuss the approval in Spain of Merus Lab’s Sintrom medication, and more. Microbiome research firm Commense licenses from the University of ...
Microbiome research and therapeutics firm Commense licensed a live biotherapeutic product for preventing childhood asthma and potentially other childhood allergic diseases from the University of Colum...
Live biotherapeutic product to be developed as an early intervention for asthma and other allergic diseases that begin in childhood PureTech Health plc (“PureTech Health” ...
We have published hundreds of Commense news stories on BioPortfolio along with dozens of Commense Clinical Trials and PubMed Articles about Commense for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Commense Companies in our database. You can also find out about relevant Commense Drugs and Medications on this site too.